Mirum Pharmaceuticals, Inc. (MIRM)
65.39
-2.51
(-3.70%)
USD |
NASDAQ |
Dec 09, 16:00
65.39
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Profit Margin (Quarterly): 2.18% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 7.47% |
| Insmed, Inc. | -260.0% |
| CorMedix, Inc. | -- |
| ADMA Biologics, Inc. | 27.14% |
| Stoke Therapeutics, Inc. | -360.7% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.73% |
| Return on Assets | -5.85% |
| Return on Invested Capital | -7.32% |
| Gross Profit Margin (Quarterly) | 80.75% |
| Operating Margin (Quarterly) | 1.96% |
| Return on Net Operating Assets | -11.27% |